Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017-2019.

Yoonyoung Choi,Alexandra Hill-Ricciuti,Angela R Branche,William D Sieling,Lisa Saiman,Edward E Walsh,Matthew Phillips,Ann R Falsey,Lyn Finelli

Influenza and other respiratory viruses（2022）

引用 18|浏览12

暂无评分

摘要

The economic burden of RSV hospitalization of adults ≥ 18 years of age in the United States is substantial. RSV vaccine programs may be useful in reducing this economic burden.

查看译文

关键词

RSV-associated hospitalization,active surveillance,adults,cost,predictors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要